Target intelligence / Profile preview

Novel transcript, antisense to NRDE2 (ENSG00000287437)

Target: ENSG00000287437
Molecular classification: Long non-coding RNA (lncRNA), Natural antisense transcript (NAT)

Overview

Novel transcript, antisense to NRDE2 (ENSG00000287437) is an annotated long non-coding RNA transcribed in the antisense orientation to the NRDE2 gene. It is classified as a natural antisense transcript (NAT). NATs can regulate gene expression through various mechanisms, including transcriptional interference, RNA masking, double-stranded RNA-dependent pathways, and modulation of chromatin structure[2][3]. However, the specific biological role, expression pattern, or clinical significance of this antisense transcript remains experimentally undefined.

Other names: antisense to NRDE2 lncRNA

Mechanism of action

Not established for this transcript.

Biological functions

Potential gene expression regulation: As a natural antisense transcript, likely roles include modulating the expression of the sense gene NRDE2 via mechanisms such as transcriptional interference, RNA masking, dsRNA-dependent mechanisms (including RNAi), or chromatin remodeling. Specific functions for ENSG00000287437 remain uncharacterized and are predicted based on the general function of NATs.

Disease associations

None specifically known. General roles for NATs in diseases such as cancer, neurological, or developmental disorders have been described, but no published evidence links this specific transcript to any disease.

Safety considerations

None reported. No evidence supporting therapeutic targeting or adverse effects.

Beyond the preview

Go deeper on Novel transcript, antisense to NRDE2 (ENSG00000287437).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, antisense to NRDE2 (ENSG00000287437).

Explore the full profile